About Cytochrome P450 3A43
Cytochrome P450 3A43 (CYP3A43) is a protein
from Homo sapiens identified by UniProt accession
Q9HB55, 503 residues long.
MolForge cross-references it against 0 known binders and
128 disease associations.
Target properties
| Protein name | Cytochrome P450 3A43 |
| UniProt accession | Q9HB55 |
| Gene | CYP3A43 |
| Organism | Homo sapiens |
| Length | 503 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (128)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.61
- HIV-1 infection · score 0.60
- COVID-19 · score 0.58
- AIDS · score 0.58
- chronic hepatitis C virus infection · score 0.57
- infection · score 0.55
- hepatitis C virus infection · score 0.55
- HIV-Associated Lipodystrophy Syndrome · score 0.46
- coronavirus infectious disease · score 0.43
- cancer · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9HB55-F1 | alphafold | PREDICTED | 91.78 | — |
Amino-acid sequence (503 residues)
MDLIPNFAME TWVLVATSLV LLYIYGTHSH KLFKKLGIPG PTPLPFLGTI LFYLRGLWNF DRECNEKYGE MWGLYEGQQP MLVIMDPDMI KTVLVKECYS VFTNQMPLGP MGFLKSALSF AEDEEWKRIR TLLSPAFTSV KFKEMVPIIS QCGDMLVRSL RQEAENSKSI NLKDFFGAYT MDVITGTLFG VNLDSLNNPQ DPFLKNMKKL LKLDFLDPFL LLISLFPFLT PVFEALNIGL FPKDVTHFLK NSIERMKESR LKDKQKHRVD FFQQMIDSQN SKETKSHKAL SDLELVAQSI IIIFAAYDTT STTLPFIMYE LATHPDVQQK LQEEIDAVLP NKAPVTYDAL VQMEYLDMVV NETLRLFPVV SRVTRVCKKD IEINGVFIPK GLAVMVPIYA LHHDPKYWTE PEKFCPERFS KKNKDSIDLY RYIPFGAGPR NCIGMRFALT NIKLAVIRAL QNFSFKPCKE TQIPLKLDNL PILQPEKPIV LKVHLRDGIT SGP
Explore Cytochrome P450 3A43 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets